TeleDaaS Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations
Imaging Technology
NOVEMBER 26, 2023
TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. Radiopharmaceuticals are revolutionizing modern cancer treatment and precision dosimetry is a crucial component of this advanced therapy.
Let's personalize your content